Reproductive Sciences publishes original, peer-reviewed, research and reviews making it one of the most highly ranked and highly cited publications in obstetrics and gynecology. Reproductive Sciences also highlights translational research in the reproductive sciences and medicine. Its aim is to fulfill the need for a publication at the interface between basic and clinical research, especially for human studies.
Reproductive Sciences provides a multi-discipline perspective, including all aspects of basic reproductive biology and medicine, maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, urogynecology, fertility/infertility, embryology, gynecologic/reproductive oncology, developmental biology, stem cell research, molecular/cellular biology and other related fields.
Among the specific topics covered are:
- Androgen action
- Breast disease
- Developmental biology
- Environmental hormones
- Extracellular matrix and signal transduction
- Gynecologic cancers
- Human stem cell research
- Infectious disease
- Male factor infertility
- Mechanisms of preterm births
- Regenerative medicine
- Reproductive genetics
- Reproductive physiology
- SERM and SPRM development
- Sex steroid hormone action
- Stem cell research
- Testis and prostate
Reproductive Sciences is the official publication of The Society for Reproductive Investigation (SRI) whose mission is the advancement of knowledge in reproductive biology.
This journal is a member of the Committee on Publication Ethics (COPE).
Reproductive Sciences is the official publication of the Society for Reproductive Investigation (SRI), whose mission is the advancement of knowledge in reproductive biology. The journal publishes original research and reviews, editorials, and position papers in all aspects of reproductive biology and its translation to clinical medicine, including the disciplines of maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, fertility/infertility, gynecologic/reproductive tract oncology, developmental biology, embryology, stem cell research, molecular/cellular biology and related fields.
This journal is a member of the Committee on Publication Ethics (COPE).
|Hugh S. Taylor, MD||Yale University School of Medicine, New Haven, CT, USA|
|Maria Rosa Maduro, PhD||Yale University School of Medicine, New Haven, CT, USA|
|Radek Bukowski, MD, PhD||Yale University School of Medicine, New Haven, CT, USA|
|Lawrence Layman, MD||Georgia Regents University, Augusta, GA, USA|
|Frederick Naftolin, MD, PhD, FACOG, FRCOG||New York University School of Medicine, New York, NY, USA|
|Errol R. Norwitz, M.D., Ph.D.||Tufts Medical Center, Boston, MA, USA|
|Charles R. Rosenfeld, MD||UT Southwestern Medical Center, Dallas, TX, USA|
|Robert S. Schenken, MD||The University of Texas Health Science Center, San Antonio, TX, USA|
|Peter E. Schwartz, MD||Yale University School of Medicine, New Haven, CT, USA|
|Joe Leigh Simpson, MD||March of Dimes Foundation, Miami, FL, USA|
|Rui Ferriani, MD, PhD||University of São Paulo, São Paulo, Brazil|
|Andrés López Bernal, MD, DPhil||University of Bristol, School of Clinical Sciences, Bristol, UK|
|SiHyun Cho, MD, PhD||Yonsei University College of Medicine, Seoul, South Korea|
|Caroline Gargett, PhD||Monash University, Victoria, Australia|
|Sun-Wei Guo, PhD||Shanghai OB/GYN Hospital, Shanghai, China|
|Yutaka Osuga, MD, PhD||The University of Tokyo Hospital, Tokyo, Japan|
|Vikki M. Abrahams, PhD||Yale University School of Medicine, New Haven, Connecticut, USA|
|Ayman Al-Hendy, MD, PhD||Georgia Regents University, Augusta, GA, USA|
|Deborah J. Anderson, PhD||Boston University School of Medicine, Boston, MA, USA|
|Jonathan S. Berek, MD||University of California Los Angeles Medical Center, Los Angeles, CA, USA|
|Ian M. Bird, PhD||University of Wisconsin-Madison, Madison, WI, USA|
|Philippe Bouchard, MD||Hôpital Saint Antoine, Paris, France|
|Steve N. Caritis, MD||University of Pittsburgh, Pittsburgh, PA, USA|
|Bruce R. Carr, MD||UT Southwestern Medical Center, Dallas, TX, USA|
|Robert F. Casper, MD||University of Toronto, Toronto, ON, Canada|
|Setsuko K. Chambers, MD||Arizona Cancer Center, Tucson, AZ, USA|
|Hilary Critchley, MD||University of Edinburgh, Edinburgh, Scotland, UK|
|Thomas D'Hooghe, MD, PhD||University Hospital Gasthuisberg, Leuven, Belgium|
|Gaurang S. Daftary, MD||Mayo Clinic College of Medicine, Rochester, Minnesota, USA|
|Alan H. DeCherney, MD||National Institutes of Health, Bethesda, MD, USA|
|Michael P. Diamond, MD||Georgia Regents University, Augusta, GA, USA|
|Sabrina Diano, PhD||Yale University, New Haven, CT, USA|
|Antoni Duleba, MD||University of California at San Diego, San Diego, CA, USA|
|Mark I. Evans, MD||Comprehensive Genetics, New York, NY, USA|
|B.C.J.M. Fauser, MD, PhD||University Medical Center, Utrecht, Netherlands|
|Asgi T. Fazleabas, PhD||Michigan State University, Grand Rapids, MI, USA|
|Idhaliz Flores, PhD||Ponce School of Medicine, Ponce, Puerto Rico, USA|
|Steve Ford, PhD||University of Wyoming, Laramie, WY, USA|
|Lisa Halvorson, MD||National Institutes of Health, Bethesda, MD, USA|
|Arne Jensen, MD||Ruhr University, Bochum, Germany|
|Omid Khorram MD, PhD||Harbor-UCLA Medical Center, Torrance, CA, USA|
|Dirk G. Kieback, MD||Helios Medical Centre, Aue, Germany|
|Brian J. Koos, Md, DPhil||UCLA Medical Center, Los Angeles, CA, USA|
|Ronald R. Magness, PhD||University of Wisconsin - Madison, Madison, WI, USA|
|Gil Mor, MD||Yale University School of Medicine, New Haven, CT, USA|
|David G. Mutch, MD||Washington University School of Medicine, St. Louis, MO, USA|
|Leslie Myatt, PhD||University of Texas Health Science Center, San Antonio, TX, USA|
|Guiying Nie, PhD||Implantation and Placental Development Laboratory Prince Henry’s Institute of Medical Research, Melbourne, Australia|
|Kutluk Oktay, MD||New York Medical College/Innovation Fertility, New York, NY, USA|
|Tanja Pejovic, MD, PhD||Oregon Health & Science University, Portland, OR, USA|
|Felice Petraglia, MD||University of Siena, Siena, Italy|
|Mark Phillippe, MD||Massachusetts General Hospital, Boston, MA, USA|
|Thomas Price, MD||Duke University Medical Center, Durham, NC, USA|
|Ch. V. Rao, PhD.||Florida International University, Miami, FL, USA|
|Fernando M. Reis, MD, PhD||Universidade Federal de Minas Gerais, Belo Horizonte, Brazil|
|Bryan S. Richardson, MD||University of Western Ontario, London, ON, Canada|
|James M. Roberts, MD||Magee-Women's Research Institute, Pittsburgh, PA, USA|
|Roberto Romero, MD||NICHD/NIH, Perinatology Research Branch, Detroit, MI, USA|
|James C. Rose, PhD.||Wake Forest University School of Medicine, Winston-Salem, NC, USA|
|Michael G. Ross, MD||Harbor-UCLA Medical Center, Torrance, CA, USA|
|Yoel Sadovsky, MD||Magee-Women's Research Institute, Pittsburgh, PA, USA|
|Mark V. Sauer, MD||Columbia University, New York, NY, USA|
|James Segars, MD||National Institutes of Health, Bethesda, MD, USA|
|Emre Seli, MD||Yale University School of Medicine, New Haven, CT, USA|
|Dinesh Shah, MD||University of Wisconsin-Madison, Madison, WI, USA|
|Carlos Simon, MD||University of Valencia, Valencia, Spain|
|Jerome F. Strauss, III, MD, PhD||Virginia Commonwealth University, Richmond, VA, USA|
|Robert N. Taylor, MD, PhD||Wake Forest School of Medicine, Winston-Salem, NC, USA|
|Eugene Toy, MD||University of Rochester Medical Center, Rochester, NY, USA|
|Scott W. Walsh, PhD||Virginia Commonwealth University, Richmond, VA, USA|
|Robert A. Wild, MD, MPH||University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA|
|Erin Wolff, MD||National Institute of Child Health and Human Development, Bethesda, MD, USA|
|Stacy Zamudio, PhD||Hackensack University MC, Newark, NJ, USA|
|Lubo Zhang, PhD||Loma Linda University School of Medicine, Loma Linda, CA, USA|
Reproductive Sciences (RS) is the highly ranked and highly cited official publication of The Society for Reproductive Investigation (SRI), whose mission is the advancement of knowledge in reproductive biology. The journal publishes original research and reviews, editorials, and position papers in all aspects of reproductive biology and its translation to clinical medicine, including the disciplines of maternal-fetal medicine, obstetrics, gynecology, reproductive endocrinology, fertility/infertility, gynecologic/reproductive tract oncology, developmental biology, embryology, stem cell research, molecular/cellular biology and related fields.
Manuscripts are accepted for consideration on the condition that they are contributed solely to RS. No substantial part of a paper may have been published elsewhere, except for a scientific abstract. Manuscripts will be reviewed by the editor, members of the editorial board, and appropriate independent referees. If the article is accepted for publication, editorial revisions may be made to aid clarity and understanding without altering the meaning.
Articles, reviews, and other text material in RS represent the opinion of the authors and do not necessarily represent the opinion of the editor, editorial board, or publisher. The editors and publisher deny any responsibility or liability for statements and opinions expressed by the authors. Neither the editor nor the publisher guarantees, warrants, or endorses any product or service advertised in this publication, nor do they guarantee any claim made by the manufacturer of such product or service.
Submission of a manuscript to the Journal is taken as evidence that no portion of the text or figures has been copyrighted, published, or submitted for publication elsewhere, unless information regarding previous publication is cited and permission obtained. A copy of permission obtained must accompany the manuscript. Transfer of copyright to the Society for Reproductive Investigation is a condition of publication and must be signed upon submission and preferentially submitted online at http://mc.manuscriptcentral.com/rsci or alternatively sent to Dr. Maria Rosa Maduro, Managing Editor, via e-mail at firstname.lastname@example.org.
Peer Review Policy
RS operates a conventional single-blind reviewing policy in which the reviewer’s name is always concealed from the submitting author.
As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:
- The reviewer should have no prior knowledge of your submission
- The reviewer should not have recently collaborated with any of the authors
- Reviewer nominees from the same institution as any of the authors are not permitted
Please note that the Editors are not obliged to invite or leave out any recommended or opposed reviewers, respectively, to assess your manuscript.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
(ii) drafted the article or revised it critically for important intellectual content,
(iii) approved the version to be published.
Please refer to the ICMJE Authorship guidelines at http://www.icmje.org/ethical_1author.html
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
All contributors who do not meet the criteria for authorship should be listed in an ‘Acknowledgements’ section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
To comply with the guidance for Research Funders, Authors and Publishers issued by the Research Information Network (RIN), RS additionally requires all Authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit Funding Acknowledgements on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding or state in your acknowledgments that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Declaration of conflicting interests
It is the policy of RS to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please include any declaration at the end of your manuscript after any acknowledgements and prior to the references, under a heading ‘Conflict of interests’. If no declaration is made the following will be printed under this heading in your article: ‘None declared’. Alternatively, you may wish to state that ‘The Author(s) declare(s) that there is no conflict of interest’.
When making a declaration the disclosure information must be specific and include any financial relationship that all authors of the article has with any sponsoring organization and the for-profit interests the organization represents, and with any for-profit product discussed or implied in the text of the article.
Any commercial or financial involvements that might represent an appearance of a conflict of interest need to be additionally disclosed in the covering letter accompanying your article to assist the Editor in evaluating whether sufficient disclosure has been made within the Declaration of Conflicting Interests provided in the article.
For more information please visit the SAGE Journal Author Gateway.
All papers reporting animal and human studies must include whether written consent was obtained from the local Ethics Committee or Institutional Review Board. Please ensure that you have provided the full name and institution of the review committee and an Ethics Committee reference number.
We accept manuscripts that report human and/or animal studies for publication only if it is made clear that investigations were carried out to a high ethical standard. Studies in humans which might be interpreted as experimental (e.g. controlled trials) should conform to the Declaration of Helsinkihttp://www.wma.net/en/30publications/10policies/b3/index.html and typescripts must include a statement that the research protocol was approved by the appropriate ethical committee. In line with the Declaration of Helsinki 1975, revised Hong Kong 1989, we encourage authors to register their clinical trials (at http://clinicaltrials.gov or other suitable databases identified by the ICMJE, http://www.icmje.org/publishing_10register.html). If your trial has been registered, please state this on the Title Page. When reporting experiments on animals, indicate on the Title Page which guideline/law on the care and use of laboratory animals was followed.
Authors are required to ensure the following guidelines are followed, as recommended by the International Committee of Medical Journal Editors, Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.
Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the submitted article.
Contributor’s publishing agreement
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive license agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and license to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
RS and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.
All manuscripts, questions, reviews, and announcements should be submitted electronically to http://mc.manuscriptcentral.com/rsci. Authors will be required to set up an online account on the SageTrack system powered by ScholarOne. All parts of the manuscript, including abstract, footnotes, tables, legends, quoted material, and case studies, must be typed double-spaced—that is, with a full line of space after every typed line. Leave generous margins—at least one inch—on both sides and at the top and bottom of every page.
On the title page, please include the following information:
1. Names, degrees, and professional affiliation (position, department, institution, place) of all authors.
2. Name of the institution where the work reported was done.
3. Acknowledgment of grant support when appropriate.
4. Mailing address, telephone, and fax of corresponding author and e-mail addresses of all authors.
The American Medical Association (AMA) Manual of Style is the standard source of style.
Average time from submission to first decision: 33 days.
The abstract should be no longer than 250 words in length. The abstract should summarize the main points of the paper and be descriptive, narrative, and informative. At the bottom of the abstract, please also submit 3-5 keywords for your article.
All tables must be cited in text. Tables are to be numbered with Arabic numerals (Table 1, Table 2) in order of their text citation. Each table should be typed (double-spaced throughout) on a separate sheet of paper and should have a title. Word table format is preferred. Each table should have a legend in sufficient detail to allow understanding without reference to the text.
Figure and Artwork Submission
Artwork includes charts and graphs, maps, photographs, line art, and tables with 17 or more columns.
Acceptable file formats include the following: TIFF, EPS, JPEG, and PDF. Microsoft application files are acceptable for vector art (line art). Scanned Images Line art (black and white) images should be scanned as a bitmap at 900ppi. Photos should be scanned as grayscale or CMYK at 300ppi.
References should be cited according to the AMA Manual of Style. In the text, please use a superscripted number that correlates with the reference at the end of the manuscript. When several references are cited simultaneously in the text, you can list the superscripted numbers together, for example, “Many researchers have debated this subject.”1,2,5,9. Use “et al” for cites of 3 authors or more in text. However, in the references, list up to 6 authors. If there are more than 6 authors, list the first 3 authors and then “et al.” Type references double-spaced at the end of the manuscript numbered in order of appearance in the manuscript. Unpublished data and personal communications should be given as references. Manuscripts in press may be referenced; however, manuscripts that have been submitted for publication but have not been accepted yet should not be referenced. A few reference examples are listed below:
Michaud G, McGowan JL, van der Jagt R, et al. Are therapeutic decisions supported by evidence from health care research? Arch Intern Med. 1998;158:1665-1668.
Cole BR. Cystinosis and cystinuria. In: Jacobson HR, Striker GE, Klahr S, eds. The Principles and Practice of Nephrology. Philadelphia, Pa: BC Decker Inc; 1991:396-403.
Sackett DL, Straus SE, Richardson WS, et al. Evidence-based Medicine: How to Practice and Teach EBM. 2nd ed. New York, NY: Churchill Livingstone; 2000.
English Language Services
Authors who would like to refine the use of English in their manuscripts might consider using the services of a professional English-language editing company. Visit http://languageservices.sagepub.com/en/ for more information. An author's use of these services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and the particular company, and any costs incurred are the sole responsibility of the author.
Prior to publication, the Publisher will send a copyedited and typeset PDF of the manuscript via e-mail to the corresponding author to review. Any corrections and alterations to the article should be submitted to the publisher prior to the deadline given in the e-mail. Authors are responsible for the accuracy of references and statistical computations.
Abstracting and Indexing
Please visit http://journals.sagepub.com/home/rsx and click on the Abstracting/Indexing link on the left-hand side to view a full list of databases in which this journal is indexed.
Advertising and Reprints
Current advertising rates and specifications may be obtained by contacting the advertising coordinator at (805) 410-7160 or by sending an e-mail to email@example.com. Reprints may be ordered by using the reprint order form that will accompany author proofs. If you need another copy of this order form, please call (805) 410-7763 or e-mail firstname.lastname@example.org.
If you or your funder wish your article to be freely available online to nonsubscribers immediately upon publication (gold open access), you can opt for it to be included in SAGE Choice, subject to the payment of a publication fee. The manuscript submission and peer review procedure is unchanged. On acceptance of your article, you will be asked to let SAGE know directly if you are choosing SAGE Choice. To check journal eligibility and the publication fee, please visit SAGE Choice. For more information on open access options and compliance at SAGE, including self/author archiving deposits (green open access) visit SAGE Publishing Policies on our Journal Author Gateway.